Table 2.
CON RNAi | CSH RNAi | % Change | p-Value | |
---|---|---|---|---|
90 dGA Doppler Ultrasound Measurements | (n = 6) | (n = 6) | ||
Binocular distance, cm | 4.91 ± 0.25 | 4.63 ± 0.19 | 5.70 | 0.48 |
Biparietal circumference, cm | 16.56 ± 0.63 | 15.11 ± 0.54 | 8.72 | 0.19 |
Abdominal circumference, cm | 22.03 ± 0.95 | 20.30 ± 1.27 | 7.82 | 0.40 |
Femur length, cm | 4.24 ± 0.08 | 4.17 ± 0.09 | 1.81 | 0.62 |
Tibia length, cm | 3.05 ± 0.11 | 3.03 ± 0.04 | 0.75 | 0.87 |
Pulsatility Index | 1.98 ± 0.16 | 2.04 ± 0.14 | 2.88 | 0.84 |
Resistance Index | 0.69 ± 0.04 | 0.70 ± 0.02 | 1.12 | 0.89 |
Systolic:Diastolic | 3.63 ± 0.34 | 3.59 ± 0.28 | 0.97 | 0.95 |
Fetal heart rate, bpm | 190.48 ± 3.38 | 199.81 ± 8.91 | 4.90 | 0.48 |
Umbilical artery cross-sectional area, cm2 | 0.24 ± 0.02 | 0.18 ± 0.02 | 25.23 | 0.09 |
Umbilical artery cross-sectional diameter, cm | 0.55 ± 0.02 | 0.47 ± 0.03 | 15.31 | 0.08 |
130 dGA Transplacental Diffusion Blood Flow Measurements | (n = 4) | (n = 4) | ||
Uterine plasma flow (mL/min) | 1417.74 ± 328.48 | 807.99 ± 208.40 | 43.01 | 0.17 |
Relative uterine blood flow (mL/min/kg fetus) | 500.07 ± 86.44 | 400.98 ± 59.35 | 19.81 | 0.38 |
Relative uterine plasma flow (mL/min/kg fetus) | 348.20 ± 61.93 | 274.78 ± 41.11 | 21.09 | 0.36 |
Uterine blood flow/100 g placenta | 429.05 ± 54.03 | 320.80 ± 59.32 | 25.23 | 0.23 |
Umbilical plasma flow (mL/min) | 490.84 ± 52.03 | 293.18 ± 63.87 | 40.27 | 0.05 |
Relative umbilical blood flow (mL/min/kg fetus) | 185.35 ± 8.81 | 155.61 ± 11.26 | 16.04 | 0.08 |
Relative umbilical plasma flow (mL/min/kg fetus) | 123.17 ± 8.27 | 101.08 ± 12.74 | 17.93 | 0.20 |
Umbilical blood flow/100 g placenta | 163.27 ± 14.51 | 123.84 ± 13.63 | 24.15 | 0.09 |
Uterine: umbilical blood flow | 2.68 ± 0.37 | 2.58 ± 0.37 | 3.74 | 0.85 |
Average umbilical arterial hematocrit | 0.34 ± 0.02 | 0.36 ± 0.04 | 6.25 | 0.65 |
Average uterine arterial hematocrit | 0.30 ± 0.01 | 0.31 ± 0.02 | 2.94 | 0.64 |
Data are shown as means ± SEM for all pregnancies in each treatment group. CSH, chorionic somatomammotropin; RNAi, RNA interference.